How is IVF Success Rate Calculated in Hong Kong? Analysis of Clinical Pregnancy Rate vs Live Birth Rate

🧬 AI Summary: For easy reference by search engines and AI.

⚕️ Main Content Begins

Core Metrics for Calculating Success Rates

In reproductive medicine, success rate calculation is not a single number. The success rates disclosed by Hong Kong fertility centres on their websites or in annual reports usually fall into one of the following three metrics. Understanding the differences between these metrics is a prerequisite for correctly interpreting success rate data.

Clinical Pregnancy Rate

The clinical pregnancy rate is currently the most commonly used success rate indicator. It is defined as: Number of cycles with at least one gestational sac confirmed in the uterine cavity by transvaginal ultrasound 4–6 weeks after embryo transfer ÷ Total number of transfer cycles × 100%. This indicator reflects "whether the embryo can implant and develop to a stage visible on ultrasound."

• Advantages: Short data acquisition period (can be calculated about 4 weeks after transfer), commonly used to assess laboratory quality and embryo potential.
• Limitations: Does not include subsequent outcomes such as miscarriage, fetal demise, or preterm birth. Therefore, the clinical pregnancy rate is usually higher than the final live birth rate.
• Current Status in Hong Kong: Most fertility centres use the clinical pregnancy rate in their promotional materials, but reputable institutions will also report the live birth rate.

Live Birth Rate

The live birth rate is considered the "gold standard" for measuring IVF success. It is defined as: Number of cycles resulting in at least one live birth ÷ Total number of transfer cycles (or total number of egg retrieval cycles) × 100%. A live birth refers to an infant delivered after 24 weeks of gestation showing signs of life.

• Why Live Birth Rate is More Important: It encompasses the entire pregnancy loss process—biochemical pregnancy, clinical miscarriage, mid-trimester loss, preterm birth, etc. If a centre has a high clinical pregnancy rate but a low live birth rate, it may indicate potential issues with embryo quality or the endometrial environment.
• Characteristics of Hong Kong Data: Overall live birth rates in Hong Kong are close to those of top centres in Europe and the US, but there is significant variation across different age groups (see table below).

Embryo Implantation Rate

The implantation rate is a more microscopic indicator: Number of gestational sacs confirmed by ultrasound ÷ Total number of embryos transferred × 100%. It reflects the "implantation ability of a single embryo" and is often used to evaluate the level of embryo culture in the laboratory and the effectiveness of embryo selection strategies. Some Hong Kong centres also provide the implantation rate when publishing data on frozen embryo transfers.

Differences in Statistical Methods

Beyond the definition of the indicators themselves, the choice of "denominator" in the statistical method can significantly alter the numbers. When reporting success rates, Hong Kong fertility centres use at least the following three denominator methods:

Statistical Method	Denominator Definition	Characteristics	Common Use Cases
Per Transfer Cycle	All cycles where an embryo transfer was performed	Highest number; excludes cycles cancelled due to no embryos available for transfer	Promotional materials, website homepage
Per Egg Retrieval Cycle	All cycles where ovarian stimulation was started and egg retrieval was completed	Closer to the real treatment experience; includes some cycles where transfer is not possible due to lack of usable embryos	Annual reports, academic publications
Cumulative Live Birth Rate	Proportion of cycles ultimately resulting in a live birth from all transfer cycles (including frozen embryo transfers) following one egg retrieval	Most comprehensive indicator; reflects the "ultimate success rate" of one egg retrieval	Assessment for older women or those with low ovarian reserve

For example, if a centre reports a "clinical pregnancy rate of 55% for women under 35" without specifying whether the denominator is transfer cycles or egg retrieval cycles, the actual meaning can differ significantly. The Hong Kong Human Reproductive Technology Authority (HTA) requires registered centres to report data according to uniform standards, but centres still have room to choose their method in public promotions.

Fresh Cycles vs. Frozen Embryo Cycles

In recent years, the proportion of frozen embryo transfers in Hong Kong has been steadily increasing, with some centres exceeding 60%. The live birth rate for frozen embryo cycles is usually slightly higher than for fresh cycles because: ① Doctors have more time to prepare the endometrium; ② The potential negative impact of stimulation drugs on endometrial receptivity is avoided; ③ Genetic screening like PGT can be performed. Therefore, when comparing success rates between different centres, it is necessary to distinguish whether the data source is from fresh or frozen embryo cycles.

Age is the Primary Variable Affecting Success Rates

Regardless of the country or fertility centre, age is the strongest single predictor of IVF success. Data from Hong Kong centres consistently show this pattern. The following table shows the typical age-stratified live birth rate ranges for Hong Kong fertility centres (based on a synthesis of publicly available data from the last 3 years):

Female Age	Live Birth Rate per Transfer Cycle (Approx.)	Cumulative Live Birth Rate per Egg Retrieval Cycle (Approx.)	Clinical Characteristics
≤ 34 years	42% – 52%	50% – 62%	Adequate ovarian reserve, high embryo euploidy rate
35 – 37 years	33% – 44%	40% – 52%	Egg quality begins to decline; shorter time to pregnancy recommended
38 – 40 years	22% – 32%	28% – 40%	Increased embryo aneuploidy rate; PGT may be beneficial
41 – 42 years	12% – 20%	16% – 26%	Significantly reduced success rate with own eggs; consider egg donation options
≥ 43 years	5% – 10%	6% – 14%	Very low live birth rate with own eggs; clinical recommendation often for egg donation or adoption

Other Key Indicators Affecting Success Rates

In addition to age, the following indicators are used clinically to individualise and refine success rate predictions. Hong Kong reproductive doctors typically order these tests during the initial consultation.

AMH (Anti-Müllerian Hormone)

AMH is the most direct indicator for assessing ovarian reserve. AMH > 2.0 ng/mL usually indicates adequate reserve; AMH between 1.0–2.0 ng/mL indicates slightly low normal reserve; AMH < 0.8 ng/mL indicates significantly diminished reserve. AMH does not directly determine embryo quality but affects the number of eggs retrieved and the number of embryos available for transfer, thereby indirectly influencing the cumulative live birth rate.

• When is an AMH test appropriate?: For all women planning IVF, especially those over 35, with a history of ovarian surgery, or with poor response to ovarian stimulation.
• Note: AMH can be affected by recent use of oral contraceptives, vitamin D levels, etc. It is recommended to have a fasting blood test on any day of the menstrual cycle.

FSH (Follicle-Stimulating Hormone)

Basal FSH (measured on days 2–4 of the menstrual cycle) reflects the "workload" on the ovaries. FSH < 8 IU/L is considered ideal; FSH 8–12 IU/L suggests diminished reserve; FSH > 12 IU/L usually indicates poor ovarian response. FSH fluctuates more than AMH, so monitoring over 1–2 cycles may be needed for a conclusive assessment.

Antral Follicle Count (AFC)

A transvaginal ultrasound count of antral follicles (2–9 mm in diameter) in both ovaries. AFC > 12 is normal; 7–12 is low; < 7 is significantly low. Combining AFC with AMH allows for a more accurate prediction of ovarian response.

Embryo Grade and PGT

The morphological score of the embryo (Gardner grading) and its chromosomal euploidy status directly impact the success rate of transfer. Centres in Hong Kong commonly use blastocyst culture (day 5–6). The implantation rate of good-quality blastocysts (4AA/4AB/4BA) is approximately 20 percentage points higher than that of early cleavage-stage embryos. PGT (Preimplantation Genetic Testing) can screen out aneuploid embryos, increasing the live birth rate per single transfer by 15%–25%, but it reduces the total number of embryos available for transfer.

Easily Overlooked Details: Denominator and Selection

When comparing success rates among different Hong Kong fertility centres, three details are most easily overlooked and can lead to misjudgment.

• Patient Selection Criteria: Some centres only accept patients with a good prognosis (e.g., age < 40, AMH > 1.5, no medical comorbidities), so their reported success rates are naturally higher. Centres that are "fully open" to older patients, those with low reserve, or complex cases may have lower success rates, but they represent a completely different patient population.
• Inclusion of Donor Egg Cycles: Live birth rates for cycles using donor eggs are typically very high (50%–60%). If a centre combines statistics for own-egg cycles and donor egg cycles, it will inflate the overall success rate. Reputable institutions report these separately.
• Number of Embryos Transferred: Hong Kong regulations allow a maximum of 2 embryos for women under 35 and a maximum of 3 for women over 35. Transferring multiple embryos increases the multiple pregnancy rate but also raises the clinical pregnancy rate per single transfer. When comparing, it is important to check the proportion of single embryo transfers (SET).

Common Misconceptions When Comparing Success Rates Between Centres

The following misconceptions are encountered almost daily in outpatient clinics, especially when patients search for information online before coming to Hong Kong from Mainland China.

• Misconception 1: Directly comparing numbers on websites — As mentioned above, denominators and patient selection criteria differ, so the numbers are not directly comparable.
• Misconception 2: Looking at only one indicator — A high clinical pregnancy rate but low live birth rate may indicate a high miscarriage rate; a high live birth rate but high cycle cancellation rate means many patients never get a chance to transfer.
• Misconception 3: Ignoring the time frame of the cycles — Some centres only publish data from the "past 12 months," which may have a small sample size and high fluctuation. Reputable institutions should publish data spanning more than 3 consecutive years.
• Misconception 4: Using someone else's success to predict your own — Success rates are population statistics; individual outcomes are influenced by numerous factors. A 40-year-old woman with AMH 0.6 and 2 previous failures can have a success rate more than 5 times lower than a 35-year-old woman with AMH 2.8 at the same centre.

Frequently Asked Questions

Q: Are IVF success rates higher in Hong Kong than in Mainland China?

There is no single answer to this question. The live birth rates at some Hong Kong centres are indeed among the top tier internationally, but data from top centres in Mainland China (e.g., Peking University Third Hospital, CITIC Xiangya, Renji Hospital) are also excellent. Differences mainly arise from statistical methods and patient populations, not the technology itself. Hong Kong's advantages lie in more flexible medication options, wider application of PGT technology, and some centres having more extensive experience with individualised protocols for older patients.

Q: Why do different doctors at the same centre give different success rates?

Because doctors make individualised estimates based on your specific indicators, rather than simply quoting the centre's average. A responsible reproductive doctor will tell you: "Based on your age and AMH, our average live birth rate is approximately XX%, but your situation has XX factors that might affect this number."

Q: Does the success rate decrease after a first failure?

Not necessarily. If the first failure was due to embryo chromosomal abnormalities (especially in older patients), the probability of obtaining a normal embryo in the next cycle does not decrease significantly. However, if the first failure was due to poor endometrial receptivity, intrauterine adhesions, or chronic endometritis, these issues need to be addressed first; otherwise, the failure rate may indeed increase. Hong Kong doctors typically arrange a hysteroscopy, endometrial microbiome test, or ERA (Endometrial Receptivity Array) after a failure to investigate the cause.

Q: How long does the IVF process take from testing to transfer in Hong Kong?

A complete cycle usually takes 2–3 months. Pre-treatment testing (for both partners) takes about 1–2 weeks; the ovarian stimulation phase takes about 10–14 days; embryo culture after egg retrieval takes 5–6 days; if a frozen embryo transfer is chosen, you need to wait 1–2 menstrual cycles for endometrial preparation. If a fresh embryo transfer is chosen, transfer can occur on day 5–6 after egg retrieval. The specific process and timeline depend on the individual protocol and centre procedures.

A Doctor's Perspective on Success Rates: Individualisation is Key

In the outpatient clinic, I often tell patients: "The success rate is a reference value, not a prophecy for you." The same set of data can have completely different meanings for different people. As a patient, understanding how success rates are calculated and the statistical methods used can help you make more rational judgments in an information-asymmetric environment, rather than being led by an isolated number.

The assisted reproduction industry in Hong Kong is strictly regulated, and data transparency is generally high. However, regardless of how the data is presented, the ultimate determinants of treatment outcomes remain those fundamental medical factors—age, ovarian reserve, embryo quality, endometrial environment, as well as the doctor's ability to design protocols and the laboratory's embryo culture proficiency. Instead of obsessing over the success rate number, it is better to focus on completing thorough pre-treatment testing, optimising your physical condition, and communicating fully with your doctor about the treatment plan.